Surveillance of bacterial meningitis, Ethiopia, 2012–2013
dc.contributor.author | Mihret, Wude | |
dc.contributor.author | Lema, Tsehaynesh | |
dc.contributor.author | Merid, Yared | |
dc.contributor.author | Kassu, Afework | |
dc.contributor.author | Abebe, Workeabeba | |
dc.contributor.author | Moges, Beyene | |
dc.contributor.author | Tenna, Admasu | |
dc.contributor.author | Woldegebriel, Fitsum | |
dc.contributor.author | Yidnekachew, Melaku | |
dc.contributor.author | Mekonnen, Wondale | |
dc.contributor.author | Yamuah, Lawrence | |
dc.contributor.author | Ahmed, Arslan | |
dc.contributor.author | Silamsaw, Mezgebu | |
dc.contributor.author | Petros, Beyene | |
dc.contributor.author | Oksnes, Jan | |
dc.contributor.author | Rosenqvist, Einar | |
dc.contributor.author | Ayele, Samuel | |
dc.contributor.author | Caugant, Dominique A | |
dc.contributor.author | Aseffa, Abraham | |
dc.contributor.author | Norheim, Gunnstein | |
dc.date.accessioned | 2017-03-02T11:49:34Z | |
dc.date.available | 2017-03-02T11:49:34Z | |
dc.date.created | 2016-06-24T08:49:21Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Emerging Infectious Diseases. 2016, 22 (1), 75-78. | |
dc.identifier.issn | 1080-6040 | |
dc.identifier.uri | http://hdl.handle.net/11250/2432716 | |
dc.description.abstract | Ethiopia has the second-largest population (≈94 million in 2013) among the meningitis belt countries of sub-Saharan Africa (1). However, during 2001–2010, a median of only 1,056 suspected meningitis cases per year (range 5–8,571/year) was reported to the World Health Organization (2). The largest meningitis epidemics occurred in 1981 (3) and 1989 (4), resulting in ≈45,000 and ≈50,000 cases, respectively. Serogroup A meningococci were the major cause of these epidemics, although serogroup C strains were also identified in 1981, 1983–84, and during outbreaks in 2000 and 2003 (5). Conjugate vaccines against Haemophilus influenzae serotype b, Streptococcus pneumoniae (pneumococcal conjugate vaccine [PCV] 10), and Neisseria meningitidis serogroup A (MenAfriVac) were introduced in 2007, 2011, and 2013–2015, respectively. Because data permitting assessment of these vaccines are limited, we implemented a surveillance study. | |
dc.language.iso | eng | |
dc.relation.uri | https://wwwnc.cdc.gov/eid/article/22/1/pdfs/15-0432.pdf | |
dc.title | Surveillance of bacterial meningitis, Ethiopia, 2012–2013 | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.source.pagenumber | 75-78 | |
dc.source.volume | 22 | |
dc.source.journal | Emerging Infectious Diseases | |
dc.source.issue | 1 | |
dc.identifier.doi | 10.3201/eid2201.150432 | |
dc.identifier.cristin | 1363886 | |
cristin.unitcode | 7502,4,0,0 | |
cristin.unitcode | 7502,4,9,0 | |
cristin.unitcode | 7502,4,6,0 | |
cristin.unitname | Smittevern, miljø og helse | |
cristin.unitname | Molekylærbiologi | |
cristin.unitname | Bakteriologi | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 2 |
Files in this item
This item appears in the following Collection(s)
-
Artikler [5061]
-
Publikasjoner fra CRIStin FHI [7531]